Oncolytics Biotech
ONCY
#10284
Rank
A$77.21 M
Marketcap
A$0.59
Share price
-7.21%
Change (1 day)
-64.21%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2026 (TTM): -A$56.44 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$42.28 Million a decrease over its 2024 earnings that were of -A$35.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$56.44 Million33.49%
2025 -A$42.28 Million20.47%
2024 -A$35.1 Million-5.22%
2023 -A$37.03 Million24.73%
2022 -A$29.69 Million-1.09%
2021 -A$30.01 Million5.72%
2020 -A$28.39 Million25.24%
2019 -A$22.67 Million28.77%
2018 -A$17.61 Million1.15%
2017 -A$17.41 Million5.2%
2016 -A$16.55 Million9.85%
2015 -A$15.06 Million-36.67%
2014 -A$23.78 Million-26.64%
2013 -A$32.41 Million-38.4%
2012 -A$52.62 Million27%
2011 -A$41.43 Million44.32%
2010 -A$28.71 Million35.97%
2009 -A$21.12 Million-3.27%
2008 -A$21.83 Million-10.71%
2007 -A$24.45 Million28.33%
2006 -A$19.05 Million40.52%
2005 -A$13.56 Million-13.75%
2004 -A$15.72 Million115.72%
2003 -A$7.29 Million16.58%
2002 -A$6.25 Million-4.4%
2001 -A$6.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$50.22 B-90,985.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.36 B-29,721.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-A$1.11 Billion 1,899.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.93 Million-85.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.31 B-4,295.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-A$41.95 Million-24.09%๐Ÿ‡บ๐Ÿ‡ธ USA